Literature DB >> 3013137

Relapsing central and peripheral demyelinating diseases. Unusual pathologic features.

S M de la Monte, A H Ropper, G R Dickersin, N L Harris, J A Ferry, E P Richardson.   

Abstract

We treated a patient who had a demyelinating peripheral neuropathy and a central nervous system inflammatory demyelinating disease. The unusual pathologic feature of dense infiltrates of atypical macrophages was observed in many areas of the brain; otherwise the process had several features in common with either multiple sclerosis or chronic relapsing experimental allergic encephalomyelitis. The illness followed "swine-flu" inoculation; exacerbation followed pneumococcal vaccination.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013137     DOI: 10.1001/archneur.1986.00520060084027

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  5 in total

Review 1.  Tumefactive demyelinating lesions.

Authors:  A P Dagher; J Smirniotopoulos
Journal:  Neuroradiology       Date:  1996-08       Impact factor: 2.804

2.  Role of toll-like receptors in multiple sclerosis.

Authors:  Socorro Miranda-Hernandez; Alan G Baxter
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

3.  Streptococcus pneumoniae Infection aggravates experimental autoimmune encephalomyelitis via Toll-like receptor 2.

Authors:  Isabel Herrmann; Markus Kellert; Hauke Schmidt; Alexander Mildner; Uwe K Hanisch; Wolfgang Brück; Marco Prinz; Roland Nau
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

4.  Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis.

Authors:  Nathan P Young; Brian G Weinshenker; Joseph E Parisi; B Scheithauer; C Giannini; Shanu F Roemer; Kristine M Thomsen; Jayawant N Mandrekar; Bradley J Erickson; Claudia F Lucchinetti
Journal:  Brain       Date:  2010-02-03       Impact factor: 13.501

5.  Demyelinating optic neuropathy with Miller-Fisher syndrome. The case for overlap syndromes with central and peripheral demyelination.

Authors:  P Toshniwal
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.